Download PDF
Dtsch Med Wochenschr 2013; 138(49): 2533-2535
DOI: 10.1055/s-0033-1349666
Pneumologie | Commentary
Pneumologie, Allergologie
© Georg Thieme Verlag KG Stuttgart · New York

Allergische Erkrankungen: Neues zu Diagnostik und Therapie

Allergic diseases: what is new?
M. Lommatzsch
1   Abteilung für Pneumologie und Internistische Intensivmedizin, Zentrum für Innere Medizin, Universitätsklinikum Rostock
› Author Affiliations
Further Information

Publication History

Publication Date:
26 November 2013 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Allergien - Rhinitis - Asthma - immunotherapy

Keywords

allergies - rhinitis - asthma - Immuntherapie
 

  • Literatur

  • 1 Abrahamsson TR, Jakobsson HE, Andersson AF et al. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 2012; 129: 434-40, 40 e1-2
    CrossrefPubMedGoogle Scholar
  • 2 Bae JM, Choi YY, Park CO et al. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 2013; 132: 110-117
    CrossrefPubMedGoogle Scholar
  • 3 Blumchen K, Ulbricht H, Staden U et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010; 126: 83-91 e1
    CrossrefPubMedGoogle Scholar
  • 4 Braunstahl GJ, Chen CW, Maykut R et al. The eXpeRience registry: the 'real-world' effectiveness of omalizumab in allergic asthma. Respir Med 2013; 107: 1141-1151
    CrossrefPubMedGoogle Scholar
  • 5 Corren J, Lemanske RF, Hanania NA et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011; 365: 1088-1098
    CrossrefPubMedGoogle Scholar
  • 6 Dang TD, Tang M, Choo S et al. Increasing the accuracy of peanut allergy diagnosis by using Ara h 2. J Allergy Clin Immunol 2012; 129: 1056-1063
    CrossrefPubMedGoogle Scholar
  • 7 Ege MJ, Mayer M, Normand AC et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011; 364: 701-709
    CrossrefPubMedGoogle Scholar
  • 8 Fokkens WJ, Lund VJ, Mullol J et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50: 1-12
    PubMedGoogle Scholar
  • 9 Haldar P, Brightling CE, Hargadon B et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360: 973-984
    CrossrefPubMedGoogle Scholar
  • 10 Heederik D, von Mutius E. Does diversity of environmental microbial exposure matter for the occurrence of allergy and asthma?. J Allergy Clin Immunol 2012; 130: 44-50
    CrossrefPubMedGoogle Scholar
  • 11 Holgate ST, Noonan M, Chanez P et al. Efficacy and safety of etanercept in moderate-to-severe asthma. Eur Respir J 2011; 37: 1352-1359
    CrossrefPubMedGoogle Scholar
  • 12 Hylander T, Latif L, Petersson-Westin U et al. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis. J Allergy Clin Immunol 2013; 131: 412-20
    CrossrefPubMedGoogle Scholar
  • 13 Illi S, Depner M, Genuneit J et al. Protection from childhood asthma and allergy in Alpine farm environments – the GABRIEL Advanced Studies. J Allergy Clin Immunol 2012; 129: 1470-7 e6
    CrossrefPubMedGoogle Scholar
  • 14 Kleine-Tebbe J, Bufe A, Ebner C et al. Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Allergo J 2009; 18: 508-537
    PubMedGoogle Scholar
  • 15 Kleine-Tebbe J, Jappe U. Molekulare Allergiediagnostik: Entwicklung und Bedeutung für die klinische Praxis. Allergologie 2013; 36: 327-349
    PubMedGoogle Scholar
  • 16 Lau S, Gerhold K, Zimmermann K et al. Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2012; 129: 1040-1047
    CrossrefPubMedGoogle Scholar
  • 17 Lommatzsch M, Korn S, Buhl R et al. Against all odds: anti-IgE for intrinsic asthma?. Thorax 2013; May 24. doi: DOI: 10.1136/thoraxjnl-2013-203738. [Epub ahead of print]
    PubMedGoogle Scholar
  • 18 Nair P, Pizzichini MM, Kjarsgaard M et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360: 985-993
    CrossrefPubMedGoogle Scholar
  • 19 Passalacqua G, Garelli V, Sclifo F et al. Sublingual immunotherapy for allergic rhinitis and conjunctivitis. Immunotherapy 2013; 5: 257-264
    CrossrefPubMedGoogle Scholar
  • 20 Pavord ID, Korn S, Howarth P et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012; 380: 651-9
    CrossrefPubMedGoogle Scholar
  • 21 Penders J, Gerhold K, Stobberingh EE et al. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol 2013; 132: 601-607 e8
    CrossrefPubMedGoogle Scholar
  • 22 Pfaar O, Cazan D, Klimek L et al. Adjuvants for immunotherapy. Curr Opin Allergy Clin Immunol 2012; 12: 648-657
    CrossrefPubMedGoogle Scholar
  • 23 Przybilla B, Rueff F, Walker A et al. Diagnose und Therapie der Bienen- und Wespengiftallergie. Allergo J 2011; 20: 318-339
    PubMedGoogle Scholar
  • 24 Senti G, Crameri R, Kuster D et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol 2012; 129: 1290-1296
    CrossrefPubMedGoogle Scholar
  • 25 Tripodi S, Frediani T, Lucarelli S et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol 2012; 129: 834-839 e8
    CrossrefPubMedGoogle Scholar
  • 26 von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol 2010; 10: 861-868
    CrossrefPubMedGoogle Scholar
  • 27 Wang M, Karlsson C, Olsson C et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008; 121: 129-134
    CrossrefPubMedGoogle Scholar
  • 28 Wenzel S, Ford L, Pearlman D et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013; 368: 2455-2466
    CrossrefPubMedGoogle Scholar
  • 29 Wenzel SE, Barnes PJ, Bleecker ER et al. A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med 2009; 179: 549-558
    CrossrefPubMedGoogle Scholar